Internal Medicine, Pulmonary Disease · Bayamon, PR
NPI
1700811437
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Carr 2 Marginal Hermanas Davila, Suite 309 Metro Medical Center
Bayamon, PR, 00959
Phone (787) 780-2877
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,035
96 services
Medicare patients, 2024
29
Average age 76
Drug cost, 2024
$1.1M
4,025 prescriptions
Company payments, 2025
$439
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hyrza M Vazquez Rivera was code 99213 (office e&m - established), 71 times for 26 patients. In total Hyrza M Vazquez Rivera billed 96 services in 5 codes, and Medicare paid $6,035.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 71 | 26 | $63.35 | $4,498 |
| 94060 Pulmonary Function Testing | Office | 11 | 11 | $24.70 | $272 |
By year: 2022 $5,127 for 77 services; 2023 $6,833 for 99 services; 2024 $6,035 for 96 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hyrza M Vazquez Rivera prescribed most often to Medicare patients was Breo Ellipta (Fluticasone/Vilanterol), with 829 prescriptions and refills. In total Hyrza M Vazquez Rivera wrote 4,025 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Breo Ellipta Fluticasone/Vilanterol | 829 | 852 | 193 | $347K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 430 | 445 | 183 | $19K |
| Fluticasone Propionate Generic | 359 | 378 | 137 | $6,492 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 252 | 253 | 64 | $167K |
| Spiriva Respimat Tiotropium Bromide | 250 | 255 | 68 | $133K |
| Montelukast Sodium Generic | 243 | 591 | 110 | $4,158 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 238 | 244 | 94 | $52K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 201 | 209 | 52 | $102K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 198 | 200 | 66 | $24K |
| Prednisone Generic | 184 | 184 | 133 | $601 |
| Symbicort Budesonide/Formoterol Fumarate | 103 | 108 | 46 | $23K |
| Arnuity Ellipta Fluticasone Furoate | 93 | 93 | 25 | $20K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 92 | 92 | 26 | $44K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 83 | 90 | 37 | $4,883 |
| Azithromycin Generic | 68 | 68 | 63 | $541 |
Brand drugs: 2,603 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hyrza M Vazquez Rivera $439 ($439 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $322.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.